General principles in the treatment of lupus nephritis with the prevention of cardiovascular events
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown etiology, which is characterized by the hyperproduction of organ-nonspecific autoantibodies to various components of the cell nucleus with the development of immunoinflammatory tissue and visceral damages. Kidney damage i...
Main Authors: | Т. A. Panafidina, Т. V. Popkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2018-12-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/855 |
Similar Items
-
Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus
by: S Iu Serikova, et al.
Published: (2008-06-01) -
Factors Associated with Renal Outcomes in an Inception Cohort of Biopsy-proven Lupus Nephritis Patients
by: Roy Tsz Chung Ho, et al.
Published: (2020-07-01) -
The Role of Autophagy in Lupus Nephritis
by: Linlin Wang, et al.
Published: (2015-10-01) -
Management of refractory lupus nephritis: challenges and solutions
by: Yo JH, et al.
Published: (2019-07-01) -
Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study
by: Yuening Kang, et al.
Published: (2020-03-01)